Owl Peak Technologies Announces Addition of Bryce Klontz to Clinical Advisory Board 

Charlottesville, VA: July 23, 2024

Owl Peak Technologies, a life sciences company developing a novel screening solution for colorectal cancer, announced today that industry veteran and investor Bryce Klontz has joined the company’s Clinical Advisory Board. Mr. Klontz will help Owl Peak Technologies reach the next stage of clinical development, preparing the company for commercial introduction.   

Bryce Klontz has over 30 years of experience in the medical technology industry and is an active investor and advisor in numerous early-stage companies. He is currently a Venture Partner at Varia Ventures and recently served as President and CEO of New View Surgical, an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS). Bryce has successfully led technical and commercial teams in the US, Europe and in Asia at companies including New View Surgical, Woven Orthopedics, and Covidien, PLC (Medtronic) where Bryce spent 14 years in leadership roles, including Marketing Director for the United States and Europe and Vice President of Surgical Devices in Asia. He also served as the global post-M&A integration lead for many of Covidien's most impactful acquisitions.   

“Bryce’s significant industry experience will complement our scientific and commercial teams to help us reach new heights in research and development, preparing us for commercialization of our novel technology. He will be an incredible addition to our executive team and I look forward to working together more closely with Bryce,” said CEO Tim Harvey.  

"I am excited to begin working with the amazing team at Owl Peak Technologies and join their effort to improve cancerous tissue detection with their novel image sensor and AI platform," said Bryce. "Improved early detection of cancerous tissue during routine screening is critical given that colorectal cancer is the third-leading cause of all cancer deaths, with the incidence of colorectal cancer growing significantly in younger people over the past few decades."